Cited by 290TGF-β signaling in diseasesMechanisms of cancer metastasisCancer Cells and Metastasis

The DOI matches its Crossref record; 33 of the 37 references it cites were found in a registry or an index.

A Specific Inhibitor of TGF-β Receptor Kinase, SB-431542, as a Potent Antitumor Agent for Human Cancers

Open access

Halder, Sunil K., Beauchamp, R. Daniel, Datta, Pran K.·2005·Neoplasia

Open this paper in CoChat — free account Open PDF

Abstract

Small molecule inhibitors of signaling pathways have proven to be extremely useful for the development of therapeutic strategies for human cancers. Blocking the tumor-promoting effects of transforming growth factor-beta (TGF-beta) in advanced stage carcinogenesis provides a potentially interesting drug target for therapeutic intervention. Although very few TGF-beta receptor kinase inhibitors (TRKI) are now emerging in preclinical studies, nothing is known about how these inhibitors might regulate the tumor-suppressive or tumor-promoting effects of TGF-beta, or when these inhibitors might be useful for treatment during cancer progression. We have investigated the potential of TRKI in new therapeutic approaches in preclinical models. Here, we demonstrate that the TRKI, SB-431542, inhibits TGF-beta-induced transcription, gene expression, apoptosis, and growth suppression. We have observed that SB-431542 attenuates the tumor-promoting effects of TGF-beta, including TGF-beta-induced EMT, cell motility, migration and invasion, and vascular endothelial growth factor secretion in human cancer cell lines. Interestingly, SB-431542 induces anchorage independent growth of cells that are growth-inhibited by TGF-beta, whereas it reduces colony formation by cells that are growth-promoted by TGF-beta. However, SB-431542 has no effect on a cell line that failed to respond to TGF-beta. This represents a novel potential application of these inhibitors as therapeutic agents for human cancers with the goal of blocking tumor invasion, angiogenesis, and metastasis, when tumors are refractory to TGF-beta-induced tumor-suppressor functions but responsive to tumor-promoting effects of TGF-beta.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1593/neo.04640

Cites

33 of 33 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

TGF-β SIGNAL TRANSDUCTION
Massagué, J. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.753 · Cited by 7,571
Lessons from hereditary colorectal cancer
Kinzler, K. W., & Vogelstein, B. (1996) · Cell · doi:10.1016/s0092-8674(00)81333-1 · Cited by 4,919
TGF-β signalling from cell membrane to nucleus through SMAD proteins
Heldin, C., Miyazono, K., & ten Dijke, P. (1997) · Nature · doi:10.1038/37284 · Cited by 3,697
TGF-β Signaling in Tumor Suppression and Cancer Progression
Derynck, R., Akhurst, R. J., & Balmain, A. (2001) · Nature Genetics · doi:10.1038/ng1001-117 · Cited by 2,275
Transcriptional control by the TGF‐β/Smad signaling system
Massagué, J., & Wotton, D. (2000) · The EMBO Journal · doi:10.1093/emboj/19.8.1745 · Cited by 1,990
SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
Inman, G. J., Nicolás, F. J., Callahan, J. F., Harling, J. D., Gaster, L. M., Reith, A. D., Laping, N. J., & Hill, C. S. (2002) · Molecular Pharmacology · doi:10.1124/mol.62.1.65 · Cited by 1,636
Cytostatic and apoptotic actions of TGF-β in homeostasis and cancer
Siegel, P. M., & Massagué, J. (2003) · Nature reviews. Cancer · doi:10.1038/nrc1208 · Cited by 1,626
Transforming growth factor-beta1 mediates epithelial to mesenchymal transdifferentiation through a RhoA-dependent mechanism.
Bhowmick, N., Ghiassi, M., Bakin, A. V., Aakre, M., Lundquist, C., Engel, M., Arteaga, C., & Moses, H. (2001) · Molecular Biology of the Cell · doi:10.1091/mbc.12.1.27 · Cited by 1,087
Mice lacking Smad3 show accelerated wound healing and an impaired local inflammatory response
Ashcroft, G. S., Yang, X., Glick, A. B., Weinstein, M., Letterio, J. J., Mizel, D. E., Anzano, M., Greenwell-Wild, T., Wahl, S. M., Deng, C., et al. (1999) · Nature Cell Biology · doi:10.1038/12971 · Cited by 911
TGF-β signaling: positive and negative effects on tumorigenesis
Wakefield, L. M. (2002) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(01)00259-3 · Cited by 827

Flagged first, then by citations

Show all 37 references

4 of the 37 references couldn’t be matched to a known paper.

Sorted by citations

Items 101–200 of 290

Upregulation of flotillin-1 promotes invasion and metastasis by activating TGF-β signaling in nasopharyngeal carcinoma
Cao, S., Cui, Y., Xiao, H., Mai, M., Wang, C., Xie, S.-H., Yang, J., Wu, S., Li, J., Song, L., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.6483 · Cited by 44
Platelets induce increased estrogen production through NF-κB and TGF-β1 signaling pathways in endometriotic stromal cells
Qi, Q., Liu, X., Zhang, Q., & Guo, S.-W. (2020) · Scientific Reports · doi:10.1038/s41598-020-57997-6 · Cited by 44
Rotavirus-induced miR-142-5p elicits proviral milieu by targeting non-canonical transforming growth factor beta signalling and apoptosis in cells
Chanda, S. D., Nandi, S., & Chawla‐Sarkar, M. (2015) · Cellular Microbiology · doi:10.1111/cmi.12544 · Cited by 44
Combined Treatment with Erlotinib and a Transforming Growth Factor-β Type I Receptor Inhibitor Effectively Suppresses the Enhanced Motility of Erlotinib-Resistant Non–Small-Cell Lung Cancer Cells
Serizawa, M., Takahashi, T., Yamamoto, N., & Koh, Y. (2013) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e318279e942 · Cited by 44
Ocean acidification inhibits initial shell formation of oyster larvae by suppressing the biosynthesis of serotonin and dopamine
Liu, Z., Zhou, Z., Zhang, Y., Wang, L., Song, X., Wang, W., Zheng, Y., Zong, Y., Lv, Z., & Song, L. (2020) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2020.139469 · Cited by 43
Extracellular Hsp90 and TGFβ regulate adhesion, migration and anchorage independent growth in a paired colon cancer cell line model
de la Mare, J., Jurgens, T., & Edkins, A. L. (2017) · BMC Cancer · doi:10.1186/s12885-017-3190-z · Cited by 42
LRG1 modulates invasion and migration of glioma cell lines through TGF-β signaling pathway
Zhong, D., He, G., Zhao, S., Li, J., Lang, Y., Ye, W., Li, Y., Jiang, C., & Li, X. (2015) · Acta Histochemica · doi:10.1016/j.acthis.2015.05.001 · Cited by 42
Smoking Attenuates Transforming Growth Factor-β–Mediated Tumor Suppression Function through Downregulation of Smad3 in Lung Cancer
Samanta, D., Gonzalez, A. L., Nagathihalli, N. S., Ye, F., Carbone, D. P., & Datta, P. K. (2012) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-11-0313 · Cited by 40
Self-citation
Progesterone Inhibits Endometrial Cancer Invasiveness by Inhibiting the TGFβ Pathway
Bokhari, A. A., Lee, L. R., Raboteau, D., Hamilton, C. A., Maxwell, G. L., Rodriguez, G. C., & Syed, V. (2014) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-14-0054 · Cited by 40
Tartrate-resistant acid phosphatase (TRAP/ACP5) promotes metastasis-related properties via TGFβ2/TβR and CD44 in MDA-MB-231 breast cancer cells
Reithmeier, A., Panizza, E., Krumpel, M., Orre, L. M., Branca, R. M., Lehtiö, J., Ek‐Rylander, B., & Andersson, G. N. (2017) · BMC Cancer · doi:10.1186/s12885-017-3616-7 · Cited by 41
Transforming growth factor-β signaling: from tumor microenvironment to anticancer therapy
Chan, M. K., Chan, E. L.-Y., Ji, Z. Z., Chan, A. S. W., Li, C., Leung, K. T., To, K., & Tang, P. M. (2023) · Exploration of Targeted Anti-tumor Therapy · doi:10.37349/etat.2023.00137 · Cited by 42
Transforming growth factor-beta: A target for cancer therapy
Kelly, R. J., & Morris, J. C. (2009) · Journal of Immunotoxicology · doi:10.3109/15476910903389920 · Cited by 41
TGF-β1 activation in human hamstring cells through growth factor binding peptides on polycaprolactone surfaces
Crispim, J. F., Fernandes, H., Fu, S., Lee, Y. W., Jonkheijm, P., & Saris, D. B. F. (2017) · Acta Biomaterialia · doi:10.1016/j.actbio.2017.01.066 · Cited by 38
Characterization of TGF-β-regulated interleukin-8 expression in human prostate cancer cells
Lu, S., & Dong, Z. (2006) · The Prostate · doi:10.1002/pros.20424 · Cited by 38
Therapeutic Targeting of Epithelial Plasticity Programs: Focus on the Epithelial-Mesenchymal Transition
Malek, R. A., Wang, H., Taparra, K., & Tran, P. T. (2017) · Cells Tissues Organs · doi:10.1159/000447238 · Cited by 40
Recombinant human PRG4 (rhPRG4) suppresses breast cancer cell invasion by inhibiting TGFβ-Hyaluronan-CD44 signalling pathway
Sarkar, A., Chanda, A., Regmi, S. C., Karve, K., Deng, L., Jay, G. D., Jirik, F. R., Schmidt, T. A., & Bonni, S. (2019) · PLoS ONE · doi:10.1371/journal.pone.0219697 · Cited by 38
Elucidating the Mechanism of Regulation of Transforming Growth Factor β Type II Receptor Expression in Human Lung Cancer Cell Lines
Halder, S. K., Cho, Y.-J., Datta, A., Anumanthan, G., Ham, A. L., Carbone, D. P., & Datta, P. K. (2011) · Neoplasia · doi:10.1593/neo.11576 · Cited by 36
Self-citation
TGFβ-Dependent Epithelial-to-Mesenchymal Transition Is Required to Generate Cardiospheres from Human Adult Heart Biopsies
Forte, E., Miraldi, F., Chimenti, I., Angelini, F., Zeuner, A., Giacomello, A., Mercola, M. A., & Messina, E. (2012) · Stem Cells and Development · doi:10.1089/scd.2012.0277 · Cited by 36
Saponins from the Roots ofPlatycodon grandiflorumSuppresses TGFβ1-Induced Epithelial-Mesenchymal Transition Via Repression of PI3K/Akt, ERK1/2 and Smad2/3 Pathway in Human Lung Carcinoma A549 Cells
Choi, J. H., Hwang, Y. P., Kim, H. G., Khanal, T., Truong, M., Jin, S. W., Han, H. J., Lee, H. S., Lee, Y. C., Chung, Y., et al. (2013) · Nutrition and Cancer · doi:10.1080/01635581.2014.853087 · Cited by 35
Synthesis and biological evaluation of 2-pyridyl-substituted pyrazoles and imidazoles as transforming growth factor-β type 1 receptor kinase inhibitors
Dewang, P. M., & Kim, D. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.05.032 · Cited by 34
Loss of NF2 Induces TGFβ Receptor 1–mediated Noncanonical and Oncogenic TGFβ Signaling: Implication of the Therapeutic Effect of TGFβ Receptor 1 Inhibitor on NF2 Syndrome
Cho, J.-H., Oh, A.-Y., Park, S., Kang, S., Yoon, M.-H., Woo, T.-G., Hong, S.-D., Hwang, J., Ha, N., Lee, H., et al. (2018) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-17-1210 · Cited by 34
Rostrocaudal patterning and neural crest differentiation of human pre-neural spinal cord progenitors in vitro
Cooper, F., Gentsch, G. E., Mitter, R., Bouissou, C., Healy, L. E., Hernandez-Rodriguez, A. R., Smith, J. C., & Bernardo, A. S. (2022) · Stem Cell Reports · doi:10.1016/j.stemcr.2022.02.018 · Cited by 34
Inhibition of transforming growth factor-β signaling potentiates tumor cell invasion into collagen matrix induced by fibroblast-derived hepatocyte growth factor
Oyanagi, J., Kojima, N., Sato, H., Higashi, S., Kikuchi, K., Sakai, K., Matsumoto, K., & Miyazaki, K. (2014) · Experimental Cell Research · doi:10.1016/j.yexcr.2014.04.009 · Cited by 33
Perspectives of small molecule inhibitors of activin receptor‑like kinase in anti‑tumor treatment and stem cell differentiation (Review)
Cui, X., Shang, S., Lv, X., Zhao, J., Qi, Y., & Liu, Z. (2019) · Molecular Medicine Reports · doi:10.3892/mmr.2019.10209 · Cited by 33
Synthesis and biological evaluation of 1-substituted-3(5)-(6-methylpyridin-2-yl)-4-(quinolin-6-yl)pyrazoles as transforming growth factor-β type 1 receptor kinase inhibitors
Jin, C. H., Krishnaiah, M., Sreenu, D., Rao, K. S., Subrahmanyam, V. B., Park, C., Son, J., Sheen, Y. Y., & Kim, D. (2011) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2011.03.008 · Cited by 32
Smad4 sensitizes colorectal cancer to 5-fluorouracil through cell cycle arrest by inhibiting the PI3K/Akt/CDC2/survivin cascade
Zhang, B., Leng, C., Wu, C., Zhang, Z., Dou, L., Luo, X., ZHANG, B., & Chen, X. (2015) · Oncology Reports · doi:10.3892/or.2015.4479 · Cited by 33
Interaction of hepatic stellate cells with neutrophils and macrophages in the liver following oncogenic kras activation in transgenic zebrafish
Yang, Q., Yan, C., & Gong, Z. (2018) · Scientific Reports · doi:10.1038/s41598-018-26612-0 · Cited by 37
Transforming Growth Factor-β Regulates the Growth of Valve Interstitial Cells in Vitro
Li, C., & Gotlieb, A. I. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.06.007 · Cited by 32
Expression of transforming growth factor β1 promotes cholangiocarcinoma development and progression
Huang, C., Aihara, A., Iwagami, Y., Yu, T., Carlson, R. I., Koga, H., Kim, M., Zou, J., Casulli, S., & Wands, J. R. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.05.038 · Cited by 32
TGF-β1 inhibits human trophoblast cell invasion by upregulating cyclooxygenase-2
Yi, Y., Cheng, J., Klausen, C., & Leung, P. C. K. (2018) · Placenta · doi:10.1016/j.placenta.2018.06.313 · Cited by 32
Strategies to target molecules that control the acquisition of a mesenchymal-like phenotype by carcinoma cells
Palena, C., Fernando, R. I., Litzinger, M. T., Hamilton, D. H., Huang, B., & Schlom, J. (2011) · Experimental Biology and Medicine · doi:10.1258/ebm.2011.010367 · Cited by 32
Transforming Growth Factor β Signaling Promotes HIV-1 Infection in Activated and Resting Memory CD4 + T Cells
Yim, L. Y., Lam, K. S., Luk, T., Mo, Y., Lu, X., Wang, J., Cheung, K., Lui, G. C.-Y., Chan, D. P. C., Wong, B. C. K., et al. (2023) · Journal of Virology · doi:10.1128/jvi.00270-23 · Cited by 30
Hyaluronic acid synthase 2 promotes malignant phenotypes of colorectal cancer cells through transforming growth factor beta signaling
Kim, Y., Lee, S. B., Shim, S., Kim, A., Park, J., Jang, W., Lee, S., Myung, J. K., Park, S., Lee, S., et al. (2019) · Cancer Science · doi:10.1111/cas.14070 · Cited by 31
Use of a TGFβ type I receptor inhibitor in mouse skin carcinogenesis reveals a dual role for TGFβ signaling in tumor promotion and progression
Markell, L. M., Pérez‐Lorenzo, R., Masiuk, K. E., Kennett, M. J., & Glick, A. B. (2010) · Carcinogenesis · doi:10.1093/carcin/bgq191 · Cited by 31
Exercise-induced lactate accumulation regulates intramuscular triglyceride metabolism via transforming growth factor-β1 mediated pathways
Nikooie, R., & sajadian, S. (2015) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2015.10.024 · Cited by 30
The Role of TGF β Signaling in Squamous Cell Cancer: Lessons from Mouse Models
Glick, A. B. (2012) · Journal of Skin Cancer · doi:10.1155/2012/249063 · Cited by 30
Novel role of STRAP in progression and metastasis of colorectal cancer through Wnt/β-catenin signaling
Yuan, G., Zhang, B., Yang, S., Jin, L., Datta, A., Bae, S., Chen, X., & Datta, P. K. (2016) · Oncotarget · doi:10.18632/oncotarget.7532 · Cited by 31
Self-citation
RETRACTED ARTICLE: Targeted immune therapy of ovarian cancer
Knutson, K. L., Karyampudi, L., Lamichhane, P., & Preston, C. C. (2014) · Cancer and Metastasis Reviews · doi:10.1007/s10555-014-9540-2 · Cited by 30
Retracted
TGF-βR inhibitor SB431542 restores immune suppression induced by regulatory B–T cell axis and decreases tumour burden in murine fibrosarcoma
Premkumar, K., & Shankar, B. S. (2020) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-020-02666-w · Cited by 29
EW‐7203, a novel small molecule inhibitor of transforming growth factor‐β (TGF‐β) type I receptor/activin receptor‐like kinase‐5, blocks TGF‐β1‐mediated epithelial‐to‐mesenchymal transition in mammary epithelial cells
Park, C., Kim, D., & Sheen, Y. Y. (2011) · Cancer Science · doi:10.1111/j.1349-7006.2011.02014.x · Cited by 32
Tight junction protein 1 is regulated by transforming growth factor-β and contributes to cell motility in NSCLC cells
Lee, S. H., Paek, A. R., Yoon, K., Kim, S. H., Lee, S. Y., & You, H. J. (2015) · BMB Reports · doi:10.5483/bmbrep.2015.48.2.035 · Cited by 27
Induction of integrin β3 by sustained ERK activity promotes the invasiveness of TGFβ-induced mesenchymal tumor cells
Hong, S.-K., Park, J., Kwon, O., Kim, K.-T., Bae, G.-Y., & Cha, H. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.04.012 · Cited by 27
Resistance training‐induced muscle hypertrophy is mediated by TGF‐β1‐Smad signaling pathway in male Wistar rats
Nikooie, R., Jafari‐Sardoie, S., Sheibani, V., & Chatroudi, A. N. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.29497 · Cited by 26
Activin A and bone metastasis
Leto, G. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.22272 · Cited by 26
Role of TGF-β signaling pathway on Tenascin C protein upregulation in a pilocarpine seizure model
Mercado-Gómez, O. F., Landgrave-Gómez, J., Arriaga-Ávila, V. S., Nebreda-Corona, A., & Guevara‐Guzmán, R. (2014) · Epilepsy Research · doi:10.1016/j.eplepsyres.2014.09.019 · Cited by 26
Mannose-Binding Lectin Inhibits Monocyte Proliferation through Transforming Growth Factor-β1 and p38 Signaling Pathways
Wang, Y., Chen, A.-D., Lei, Y., Shan, G., Zhang, L., Lu, X., & Chen, Z. (2013) · PLoS ONE · doi:10.1371/journal.pone.0072505 · Cited by 26
Pentabromophenol suppresses TGF-β signaling by accelerating degradation of type II TGF-β receptors via caveolae-mediated endocytosis
Chen, C., Yang, P.-H., Kao, Y.-C., Chen, P., Chung, C., & Wang, S. (2017) · Scientific Reports · doi:10.1038/srep43206 · Cited by 25
Sustained Delivery of SB-431542, a Type I Transforming Growth Factor Beta-1 Receptor Inhibitor, to Prevent Arthrofibrosis
Lee, A. J., Mahoney, C. M., Cai, C. C., Ichinose, R., Stefani, R. M., Marra, K. G., Ateshian, G. A., Shah, R. P., Vunjak‐Novakovic, G., & Hung, C. T. (2021) · Tissue Engineering Part A · doi:10.1089/ten.tea.2021.0029 · Cited by 24
5-Aminosalicylic acid inhibits TGF-β1 signalling in colorectal cancer cells
Koelink, P. J., Hawinkels, L. J. A. C., Wiercinska, E., Sier, C. F. M., ten Dijke, P., Lamers, C. B. H. W., Hommes, D. W., & Verspaget, H. W. (2009) · Cancer Letters · doi:10.1016/j.canlet.2009.05.033 · Cited by 24
Transforming growth factor-β in tumor microenvironment: Understanding its impact on monocytes and macrophages for its targeting
Hourani, T., Sharma, A., Luwor, R. B., & Achuthan, A. A. (2024) · International Reviews of Immunology · doi:10.1080/08830185.2024.2411998 · Cited by 24
Anti-tumor activity of arjunolic acid against Ehrlich Ascites Carcinoma cells in vivo and in vitro through blocking TGF-β type 1 receptor
Elsherbiny, N. M., & Al-Gayyar, M. M. H. (2016) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.04.046 · Cited by 23
Differential Proteome Analysis Identifies TGF-β-Related Pro-Metastatic Proteins in a 4T1 Murine Breast Cancer Model
Sato, M., Matsubara, T., Adachi, J., Hashimoto, Y., Fukamizu, K., Kishida, M., Yang, Y.-A., Wakefield, L. M., & Tomonaga, T. (2015) · PLoS ONE · doi:10.1371/journal.pone.0126483 · Cited by 23
The effects of polymorphisms in 7 candidate genes on resistance to Salmonella Enteritidis in native chickens
Tohidi, R., Idris, I., Panandam, J. M., & Bejo, M. H. (2013) · Poultry Science · doi:10.3382/ps.2012-02797 · Cited by 23
Tumors Initiated by Constitutive Cdk2 Activation Exhibit Transforming Growth Factor β Resistance and Acquire Paracrine Mitogenic Stimulation during Progression
Corsino, P. E., Davis, B. J., Law, M. E., Chytil, A., Forrester, E., Nørgaard, P. H., Teoh, N., & Law, B. K. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3815 · Cited by 22
Role of TGF-β-induced Claudin-4 expression through c-Jun signaling in non-small cell lung cancer
Rachakonda, G., Vu, T., Jin, L., Samanta, D., & Datta, P. K. (2016) · Cellular Signalling · doi:10.1016/j.cellsig.2016.07.006 · Cited by 22
Self-citation
TRIP-1 regulates TGF-β1-induced epithelial-mesenchymal transition of human lung epithelial cell line A549
Perez, R. E., Navarro, A., Rezaiekhaligh, M. H., Mabry, S. M., & Ekekezie, I. I. (2011) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00350.2010 · Cited by 21
Inhibition of Non-Small Cell Lung Cancer Cells by Oxy210, an Oxysterol-Derivative that Antagonizes TGFβ and Hedgehog Signaling
Stappenbeck, F., Wang, F., Tang, L.-Y., Zhang, Y. E., & Parhami, F. (2019) · Cells · doi:10.3390/cells8101297 · Cited by 21
Distinct roles of transforming growth factor-β signaling and transforming growth factor-β receptor inhibitor SB431542 in the regulation of p21 expression
Koo, B.-S., Kim, Y., Cho, Y. J., & Kim, D. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.07.032 · Cited by 21
Par6 is an essential mediator of apoptotic response to transforming growth factor beta in NMuMG immortalized mammary cells
Avery-Cooper, G., Doerr, M. D., Gilbert, R. W. D., Youssef, M., Richard, A. F., Huether, P., & Viloria‐Petit, A. (2014) · Cancer Cell International · doi:10.1186/1475-2867-14-19 · Cited by 20
SAHA, an HDAC inhibitor, overcomes erlotinib resistance in human pancreatic cancer cells by modulating E-cadherin
Park, S., Kim, S.-M., Moon, J.-H., Kim, J. H., Shin, J.-S., Hong, S.-W., Shin, Y. J., Lee, D., Lee, E. Y., Hwang, I.-Y., et al. (2015) · Tumor Biology · doi:10.1007/s13277-015-4216-2 · Cited by 20
Suppression of TGF-β and ERK Signaling Pathways as a New Strategy to Provide Rodent and Non-Rodent Pluripotent Stem Cells
Farzaneh, M., Derakhshan, Z., Hallajzadeh, J., Sarani, N. H., Nejabatdoust, A., & Khoshnam, S. E. (2019) · Current Stem Cell Research & Therapy · doi:10.2174/1871527318666190314110529 · Cited by 19
Expansion and maintenance of primary corneal epithelial stem/progenitor cells by inhibition of TGFβ receptor I-mediated signaling
Hu, L., Pu, Q., Zhang, Y., Ma, Q., Li, G., & Li, X. (2019) · Experimental Eye Research · doi:10.1016/j.exer.2019.03.014 · Cited by 20
Nutlin-3 inhibits epithelial–mesenchymal transition by interfering with canonical transforming growth factor-β1-Smad-Snail/Slug axis
Wu, Y., Fu, Y., Zheng, L., Lin, G., Ma, J., Lou, J.-S., Zhu, H., He, Q., & Yang, B. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.08.039 · Cited by 20
Inhibition of breast cancer cell motility with a non-cyclooxygenase inhibitory derivative of sulindac by suppressing TGFβ/miR-21 signaling
Yi, B., Chang, H., Ma, R., Feng, X., Li, W., Piazza, G. A., & Xi, Y. (2016) · Oncotarget · doi:10.18632/oncotarget.6888 · Cited by 19
Identification and functional analysis of transforming growth factor-β type I receptor (TβR1) from Scylla paramamosain: The first evidence of TβR1 involved in development and innate immunity in crustaceans
Zhou, Y.-L., Wang, C., Gu, W.-B., Zhu, Q.-H., Wang, L.-Z., Zhou, Z., Liu, Z.-P., Chen, Y.-Y., & Shu, M.-A. (2018) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2018.07.018 · Cited by 19
Heterotaxin: A TGF-β Signaling Inhibitor Identified in a Multi-Phenotype Profiling Screen in Xenopus Embryos
Dush, M. K., McIver, A. L., Parr, M., Young, D. D., Fisher, J. C., Newman, D. R., Sannes, P. L., Hauck, M., Deiters, A., & Nascone‐Yoder, N. M. (2011) · Chemistry & Biology · doi:10.1016/j.chembiol.2010.12.008 · Cited by 19
Activation of the TGF-β/Smad signaling pathway in oncogenic transformation by v-Rel
Tiwari, R., Bargmann, W., & Bose, H. R. (2011) · Virology · doi:10.1016/j.virol.2011.02.002 · Cited by 18
Yiqi Huayu Jiedu Decoction Inhibits the Invasion and Metastasis of Gastric Cancer Cells through TGF‐β/Smad Pathway
Wu, T., Lü, J., Zheng, P.-Q., Liu, S.-L., Wu, J., Sun, W. Y., Sun, Q., Ma, N.-X., Ding, X.-L., Chen, M., et al. (2017) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2017/1871298 · Cited by 18
Transforming growth factor-β1 impairs CFTR-mediated anion secretion across cultured porcine vas deferens epithelial monolayer via the p38 MAPK pathway
Yi, S., Pierucci‐Alves, F., & Schultz, B. D. (2013) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00121.2013 · Cited by 17
Spatio-Temporal Distribution of Smads and Role of Smads/TGF-β/BMP-4 in the Regulation of Mouse Bladder Organogenesis
Islam, S. S., Mokhtari, R. B., Kumar, S., Maalouf, J., Arab, S., Yeger, H., & Farhat, W. A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061340 · Cited by 17
Activin A-Smad Signaling Mediates Connective Tissue Growth Factor Synthesis in Liver Progenitor Cells
Ding, Z., Jin, G.-N., Wang, W., Sun, Y., Chen, W., Chen, L., Liang, H., Datta, P. K., Zhang, M., Zhang, B., et al. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17030408 · Cited by 17
Self-citation
Endothelial-to-Mesenchymal Transition in Health and Disease: Molecular Insights and Therapeutic Implications
Kim, R., & Chang, W. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262311724 · Cited by 21
Immune Targeting of Tumor Epithelial–Mesenchymal Transition via Brachyury-Based Vaccines
Palena, C., & Hamilton, D. H. (2015) · Advances in cancer research · doi:10.1016/bs.acr.2015.04.001 · Cited by 15
Disruption of the transforming growth factor-β pathway by tolfenamic acid via the ERK MAP kinase pathway
Zhang, X., Min, K., Liggett, J. L., & Baek, S. J. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt250 · Cited by 17
Validation of the effects of TGF-β1 on tumor recurrence and prognosis through tumor retrieval and cell mechanical properties
Wu, T.-H., Chou, Y.-W., Chiu, P.-H., Tang, M., Hu, C.-W., & Yeh, M. (2014) · Cancer Cell International · doi:10.1186/1475-2867-14-20 · Cited by 15
Down-regulation of TGF-β RII expression is correlated with tumor growth and invasion in non-functioning pituitary adenomas
Gu, Y., & Feng, Y.-G. (2017) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2017.07.033 · Cited by 15
A Programmable Multifunctional 3D Cancer Cell Invasion Micro Platform
Liu, Q., Muralidharan, A., Saateh, A., Ding, Z., ten Dijke, P., & Boukany, P. E. (2022) · Small · doi:10.1002/smll.202107757 · Cited by 14
Exploiting the Convergence of Embryonic and Tumorigenic Signaling Pathways to Develop New Therapeutic Targets
Abbott, D. E., Postovit, L.-M. M., Seftor, E. A., Margaryan, N. V., Seftor, R. E. B., & Hendrix, M. J. C. (2007) · Stem Cell Reviews and Reports · doi:10.1007/s12015-007-0010-x · Cited by 14
Orchestrated desaturation reprogramming from stearoyl‐CoA desaturase to fatty acid desaturase 2 in cancer epithelial‐mesenchymal transition and metastasis
Chen, Z., Gong, Y., Chen, F., Lee, H. J., Qian, J., Zhao, J. C., Zhang, W., Li, Y., Zhou, Y., Xu, Q., et al. (2024) · 癌症：英文版 · doi:10.1002/cac2.12644 · Cited by 13
The non-detergent sulfobetaine-201 acts as a pharmacological chaperone to promote folding and crystallization of the type II TGF-β receptor extracellular domain
Wangkanont, K., Forest, K. T., & Kiessling, L. L. (2015) · Protein Expression and Purification · doi:10.1016/j.pep.2015.06.001 · Cited by 13
Identification of Adamts4 as a novel adult cardiac injury biomarker with therapeutic implications in patients with cardiac injuries
Khanam, R., Sengupta, A., Mukhopadhyay, D., & Chakraborty, S. (2022) · Scientific Reports · doi:10.1038/s41598-022-13918-3 · Cited by 13
Contraction Dynamics of Rod Microtissues of Gingiva-Derived and Periodontal Ligament-Derived Cells
Oberoi, G. C., Janjić, K., Müller, A. S., Schädl, B., Andrukhov, O., Moritz, A., & Agis, H. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.01683 · Cited by 13
TRIP-1 via AKT modulation drives lung fibroblast/myofibroblast trans-differentiation
Nyp, M. F., Navarro, A., Rezaiekhaligh, M. H., Perez, R. E., Mabry, S. M., & Ekekezie, I. I. (2014) · Respiratory Research · doi:10.1186/1465-9921-15-19 · Cited by 13
Caging Bioactive Triarylimidazoles: An Approach to Create Visible Light-Activatable Drugs
Qi, J., Amrutha, A. S., Ishida‐Ishihara, S., Dokainish, H. M., Hashim, P. K., Miyazaki, R., Tsuda, M., Tanaka, S., & Tamaoki, N. (2024) · Journal of the American Chemical Society · doi:10.1021/jacs.4c04468 · Cited by 12
Bone morphogenetic proteins, activins, and growth and differentiation factors in tumor immunology and immunotherapy resistance
Ganjoo, S., Puebla‐Osorio, N., Nanez, S., Hsu, E. Y., Voss, T. A., Barsoumian, H. B., Duong, L. K., Welsh, J. W., & Cortez, M. A. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1033642 · Cited by 13
Other targeted drugs in melanoma.
González‐Cao, M., Rodon, J. A., Karachaliou, N., Sanchez, J. M., Santarpía, M., Viteri, S., Pilotto, S., Teixidó, C., Riso, A. A., & Rosell, R. (2015) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2305-5839.2015.08.12 · Cited by 15
Epithelial‐to‐mesenchymal transition of human lung alveolar epithelial cells in a microfluidic gradient device
Kim, S. H., Hwang, S. M., Lee, J. M., Kang, J. H., Chung, I. Y., & Chung, B. G. (2012) · Electrophoresis · doi:10.1002/elps.201200386 · Cited by 12
Elevated transforming growth factor β signaling activation in β‐actin‐knockout mouse embryonic fibroblasts enhances myofibroblast features
Xie, X., & Percipalle, P. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26808 · Cited by 12
A549 cells contain enlarged mitochondria with independently functional clustered mtDNA nucleoids
Nasonovs, A., García–Díaz, M., & Bogenhagen, D. F. (2021) · PLoS ONE · doi:10.1371/journal.pone.0249047 · Cited by 14
Targeting stemness pathways modulates macrophage polarization and reprograms the tumor microenvironment
Butkute, A., Baltramonaitis, M., Malmige, S., Darinskas, A., Pašukonienė, V., & Mlynska, A. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1513404 · Cited by 11
Ets Related Gene and Smad3 Proteins Collaborate to Activate Transforming Growth Factor-Beta Mediated Signaling Pathway in ETS Related Gene-Positive Prostate Cancer Cells
Fang, J., Xu, H., Yang, C., Morsalin, S., Kayarthodi, S., Rungsrisuriyachai, K., Gunnal, U., Mckenzie, B., Rao, V. N., & Reddy, E. S. P. (2014) · Journal of Pharmaceutical Sciences and Pharmacology · doi:10.1166/jpsp.2014.1022 · Cited by 11
Therapeutic Strategies to Target TGF-β in the Treatment of Bone Metastases
Buijs, J. T., Juárez, P., & Guise, T. A. (2011) · Current Pharmaceutical Biotechnology · doi:10.2174/138920111798808293 · Cited by 12
An Application of Photoactivatable Substrate for the Evaluation of Epithelial-mesenchymal Transition Inhibitors
Nakanishi, J., Sugiyama, K., Matsuo, H., Takahashi, Y., Ōmura, S., & Nakashima, T. (2018) · Analytical Sciences · doi:10.2116/analsci.18sdp07 · Cited by 11
Transcription factor overexpression drives reliable differentiation of retinal pigment epithelium from human induced pluripotent stem cells
Dewell, T. E., Gjoni, K., Liu, A. Z., Libby, A. R. G., Moore, A. T., So, P.-L., & Conklin, B. R. (2021) · Stem Cell Research · doi:10.1016/j.scr.2021.102368 · Cited by 11
Inhibitory Smads suppress pancreatic stellate cell activation through negative feedback in chronic pancreatitis
Lin, H., Dong, B., Qi, L., Wei, Y.-X., Zhang, Y., Cai, X., Zhang, Q., Li, J., & Li, L. (2021) · Annals of Translational Medicine · doi:10.21037/atm-20-4282 · Cited by 11
Identification of a SNAI1 enhancer RNA that drives cancer cell plasticity
Fan, C., Wang, Q., Krijger, P. H. L., Cats, D., Selle, M., Khorosjutina, O., Dhanjal, S., Schmierer, B., Mei, H., de Laat, W. L., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-58032-w · Cited by 13
Contact by melanoma cells causes malignant transformation of human epithelial-like stem cells via alpha V integrin activation of transforming growth factor β 1 signaling
Sun, H., Hu, K., Wu, M., Xiong, J., Li, Y., Tang, Y., Yang, Y., & Liu, H. (2011) · Experimental Biology and Medicine · doi:10.1258/ebm.2010.010106 · Cited by 10
Thrombospondin-1 promotes fibro-adipogenic stromal expansion and contractile dysfunction of the diaphragm in obesity
Buras, E. D., Woo, M., Verma, R. K., Kondisetti, S. H., Davis, C. S., Claflin, D. R., Converso‐Baran, K., Michele, D. E., Brooks, S. V., & Chun, T. (2024) · JCI Insight · doi:10.1172/jci.insight.175047 · Cited by 9
Targeting TGF ‐β signaling, oxidative stress, and cellular senescence rescues osteoporosis in gerodermia osteodysplastica
Chan, W. L., Bucher, C. H., Goldes, J., Ma, A. C., Steiner, M., Willie, B. M., Mundlos, S., & Kornak, U. (2024) · Aging Cell · doi:10.1111/acel.14322 · Cited by 10
Receptor mimicking TGF-β1 binding peptide for targeting TGF-β1 signaling
Belair, D. G., Lee, J. S., Kellner, A. V., Huard, J., & Murphy, W. L. (2020) · Biomaterials Science · doi:10.1039/d0bm01374a · Cited by 9

Authors: Halder, S. K., Beauchamp, R. D., & Datta, P. K.
Affiliations: Vanderbilt University (US)
Corresponding author: Datta, Pran K.
ORCID: Beauchamp, R. Daniel
Datta, Pran K.
Venue: Neoplasia
Publisher: Elsevier BV
Published: 2005-05
Volume: 7
Issue: 5
Pages: 509-521
ISSN: 1476-5586 (ISSN-L)
DOI: 10.1593/neo.04640
PMC: PMC1501161
OpenAlex: W1990842005
Cited by: 288
References: 37
Citations by year: 2026: 10 · 2025: 18 · 2024: 13 · 2023: 9 · 2022: 13 · 2021: 8 · 2020: 16 · 2019: 18 · 2018: 14 · 2017: 11 · 2016: 14 · 2015: 18 · 2014: 18 · 2013: 16 · 2012: 16
FWCI: 4.14
Type: journal article
Language: en
Open access: gold
doi.org
Licence: cc-by-nc-nd
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
creativecommons.org/licenses/by-nc-nd/3.0/ (vor, 3291 d)
Locations: Neoplasia (publishedVersion, cc-by-nc-nd)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders: Cancer Research Institute
GlaxoSmithKline
Virginia Marine Resources Commission
National Cancer Institute (R01CA095195, 5P50CA90949, R01CA95195, R01CA069457, CA-69457, P50CA090949)
National Institute of Diabetes and Digestive and Kidney Diseases (R01DK52334, R01DK052334)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mechanisms of cancer metastasis
Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
Keywords: SB431542, TGF-beta, anticancer agents, epithelial-mesenchymal transition, tumor invasion, angiogenesis, metastasis, apoptosis, anchorage-independent growth, colony formation, cell motility, vascular endothelial growth factor, TGF-beta signaling
MeSH terms: Receptor, Transforming Growth Factor-beta Type I, Animals, Antineoplastic Agents, Benzamides, Cell Adhesion, Cell Line, Cell Movement, Dioxoles, Enzyme Inhibitors, Humans, Mink, Models, Biological, Neoplasm Invasiveness, Neoplasm Metastasis, Neovascularization, Pathologic, Time Factors, Transcription, Genetic, Blotting, Western, Gene Expression Regulation, Neoplastic, Transforming Growth Factor beta, Apoptosis, Protein Serine-Threonine Kinases, Receptors, Transforming Growth Factor beta, Activin Receptors, Type I, Vascular Endothelial Growth Factor A, Cell Line, Tumor, Immunoprecipitation, Mice, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

A Specific Inhibitor of TGF-β Receptor Kinase, SB-431542, as a Potent Antitumor Agent for Human Cancers

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks